Safety, Tolerability, and Efficacy of Bexicaserin in a Cohort of Participants With Developmental and Epileptic Encephalopathies: Interim Results of a Phase 1b/2a PACIFIC Study Open-Label Extension (S20.005)

To assess the long-term safety, tolerability, and efficacy of bexicaserin in participants newly exposed to bexicaserin.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000209114
Citations
3
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
4.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety, Tolerability, and Efficacy of Bexicaserin in a Cohort of Participants With Developmental and Epileptic Encephalopathies: Interim Results of a Phase 1b/2a PACIFIC Study Open-Label Extension (S20.005)

Sheila H. Smith, Shikha Polega, Ngọc Minh Lê, Morgan Weberg
3 citations
Neurology
Epilepsy research and treatment
4.41
article

Safety, Tolerability, and Efficacy of Bexicaserin in a Cohort of Participants With Developmental and Epileptic Encephalopathies: Interim Results of a Phase 1b/2a PACIFIC Study Open-Label Extension (S20.005)

Sheila H. Smith, Shikha Polega, Ngọc Minh Lê, Morgan Weberg
article en
3 citations

Abstract

To assess the long-term safety, tolerability, and efficacy of bexicaserin in participants newly exposed to bexicaserin.

NeurologyVol. 104(7_Supplement_1)
Eboo Pharmaceuticals (United States) (US)
Zero hunger
Openalex Percentile: Top 6%
Epilepsy research and treatment
4.41
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safety, Tolerability, and Efficacy of Bexicaserin in a Cohort of Participants With Developmental and Epileptic Encephalopathies: Interim Results of a Phase 1b/2a PACIFIC Study Open-Label Extension (S20.005) — Sheila H. Smith, Shikha Polega, et al. · Neurology (2025) | TGRS Research Map | TGRS